ES2052647T3 - Procedimiento para la produccion de un preparado combinado farmaceutico. - Google Patents

Procedimiento para la produccion de un preparado combinado farmaceutico.

Info

Publication number
ES2052647T3
ES2052647T3 ES88112332T ES88112332T ES2052647T3 ES 2052647 T3 ES2052647 T3 ES 2052647T3 ES 88112332 T ES88112332 T ES 88112332T ES 88112332 T ES88112332 T ES 88112332T ES 2052647 T3 ES2052647 T3 ES 2052647T3
Authority
ES
Spain
Prior art keywords
procedure
production
combined preparation
pharmaceutical combined
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88112332T
Other languages
English (en)
Inventor
Elmar Dr Schrinner
Irvin Dr Winkler
Christoph Dr Meichsner
Matthias Dr Helsberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2052647T3 publication Critical patent/ES2052647T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PREPARADOS COMBINACIONES FARMACEUTICOS QUE CONTIENEN O CONSTAN DE A) AL MENOS UN POLISACARIDO SULFATADO Y B) AL MENOS UN DERIVADO DE XANTINA. EL PREPARADO RESULTA APROPIADO PARA LA LUCHA Y LA PROFILAXIS DE ENFERMEDADES VIRICAS, ESPECIALMENTE DE AQUELLAS OCASIONADAS POR RETROVIRUS.
ES88112332T 1987-08-01 1988-07-29 Procedimiento para la produccion de un preparado combinado farmaceutico. Expired - Lifetime ES2052647T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3725554A DE3725554A1 (de) 1987-08-01 1987-08-01 Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung

Publications (1)

Publication Number Publication Date
ES2052647T3 true ES2052647T3 (es) 1994-07-16

Family

ID=6332870

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88112332T Expired - Lifetime ES2052647T3 (es) 1987-08-01 1988-07-29 Procedimiento para la produccion de un preparado combinado farmaceutico.

Country Status (18)

Country Link
US (1) US5055457A (es)
EP (1) EP0305743B1 (es)
JP (1) JPS6450821A (es)
KR (1) KR890003383A (es)
CN (1) CN1031184A (es)
AT (1) ATE81980T1 (es)
AU (1) AU617115B2 (es)
CA (1) CA1328404C (es)
DE (2) DE3725554A1 (es)
DK (1) DK425288A (es)
ES (1) ES2052647T3 (es)
GR (1) GR3006992T3 (es)
HU (1) HU204999B (es)
IL (1) IL87287A0 (es)
NO (1) NO174834C (es)
NZ (1) NZ225611A (es)
PT (1) PT88150B (es)
ZA (1) ZA885577B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3842362A1 (de) * 1988-12-16 1990-06-28 Hoechst Ag Pharmazeutische kombinationspraeparate enthaltend nucleosid-derivate und pentosanpolysulfat, sowie deren herstellung und verwendung
US5272261A (en) * 1989-01-11 1993-12-21 Merrell Dow Pharmaceuticals Inc. Preparation of sulfated polysaccharide fractions
EP0410002B1 (en) * 1989-02-10 1995-11-22 Taiho Pharmaceutical Co., Ltd. Anti-hiv drug
IE902574A1 (en) * 1989-07-17 1991-02-27 Univ Birmingham Antiviral pyrimidine nucleosides
DE3928769A1 (de) * 1989-08-31 1991-03-14 Ulrich Dr Med Kuebler Verfahren und pharmazeutische mischung zur aufrechterhaltung und wiederherstellung des zinkgehaltes von retroviral infizierten zellen, sowie zur unterdrueckung und prophylaxe der transformierung von humanen b-lymphozyten durch eb-viren
DE4021066A1 (de) * 1990-07-03 1992-01-09 Hoechst Ag Langzeitprophylaxe gegen erkrankungen, die durch viren oder durch unkonventionelle viren verursacht werden
US5521163A (en) * 1990-07-13 1996-05-28 University Of Birmingham Antiviral pyrimidine nucleosides and methods for using same
US5514667A (en) * 1990-11-05 1996-05-07 Arthropharm Pty. Limited Method for topical treatment of herpes infections
ATE138266T1 (de) * 1990-11-07 1996-06-15 Hoechst Roussel Pharma Verwendung von xanthinen zur herstellung von arzneimitteln zur hemmung der vermehrung menschlicher retroviren
US5603963A (en) * 1994-07-28 1997-02-18 University Of Cincinnati Method for the treatment of retroviral diseases such as acquired immune deficiency syndrome utilizing (pseudo)halogen complexes of gold(1)
US5643892A (en) * 1995-06-07 1997-07-01 Baker Norton Pharmaceuticals, Inc. Method of treating chronic progressive vascular diseases
DE10063111A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Replikationsassay zur Auffindung antiviraler Substanzen
US20080004236A1 (en) * 2004-02-06 2008-01-03 Comper Wayne D High Dose, Short Interval Use of Sulfated Polysaccharides for Treatment of Infections
RU2468106C1 (ru) * 2011-05-31 2012-11-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Сплав на основе алюминия

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3175942A (en) * 1962-03-13 1965-03-30 Evans Medical Ltd Gastro-intestinal therapeutic
DE2335170C2 (de) * 1973-07-11 1989-07-20 Hoechst Ag, 6230 Frankfurt 1,3-Dialkyl-7-(hydroxyalkyl)-xanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2364373A1 (de) * 1973-12-22 1975-07-10 Hahn Carl Dr Gmbh Pharmazeutische und kosmetische praeparate zur aeusserlichen anwendung
DE3173289D1 (en) * 1980-06-21 1986-02-06 Beecham Wuelfing Gmbh & Co Kg Xanthine derivatives, pharmaceutical compositions containing them and a process for their preparation
US4533493A (en) * 1981-08-27 1985-08-06 Miles Laboratories, Inc. Theophylline immunogens, antibodies, labeled conjugates, and related derivatives
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
DE3640610A1 (de) * 1986-11-27 1988-06-09 Uhde Gmbh Verfahren und vorrichtung zum konditionieren von wasserhaltigem schuettgutmaterial
NZ222695A (en) * 1986-11-29 1990-03-27 Ueno Seiyaku Oyo Kenkyujo Kk Synergistic antiviral compositions
AU609234B2 (en) * 1987-12-21 1991-04-26 Forest Laboratories, Inc. Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system

Also Published As

Publication number Publication date
ZA885577B (en) 1989-04-26
PT88150A (pt) 1989-06-30
DE3725554A1 (de) 1989-02-09
NO883375L (no) 1989-02-02
ATE81980T1 (de) 1992-11-15
NZ225611A (en) 1991-09-25
HU204999B (en) 1992-03-30
NO174834B (no) 1994-04-11
KR890003383A (ko) 1989-04-14
JPS6450821A (en) 1989-02-27
DK425288A (da) 1989-02-02
IL87287A0 (en) 1989-01-31
EP0305743A2 (de) 1989-03-08
PT88150B (pt) 1995-03-01
DE3875674D1 (de) 1992-12-10
CN1031184A (zh) 1989-02-22
US5055457A (en) 1991-10-08
NO174834C (no) 1994-07-20
GR3006992T3 (es) 1993-06-30
EP0305743A3 (en) 1990-04-04
AU2017988A (en) 1989-02-02
NO883375D0 (no) 1988-07-29
EP0305743B1 (de) 1992-11-04
DK425288D0 (da) 1988-07-29
CA1328404C (en) 1994-04-12
HUT52957A (en) 1990-09-28
AU617115B2 (en) 1991-11-21

Similar Documents

Publication Publication Date Title
ES2052647T3 (es) Procedimiento para la produccion de un preparado combinado farmaceutico.
ES550807A0 (es) Un procedimiento para la produccion de un preparado farmaceutico de liberacion lenta y controlada.
NO900077L (no) Fremgangsmaate for fremstilling av azitromycin-dihydrat.
NO870240D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
MX7769A (es) Procedimiento para la preparacion de derivados de pirimidina.
ES2037808T3 (es) Procedimiento para la obtencion de medicamentos para la profilaxis y terapia de enfermedades producidas por retrovirus.
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
ES2145360T3 (es) Sales cristalinas y estables de acido tetrahidrofolico.
GR3004440T3 (es)
SE8704952D0 (sv) Farmaceutisk komposition
NO167980C (no) Analogifremgangsmaate for fremstilling av tienoimidazol-derivater.
IT8721687A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropiridin-3-carbossa ldeide, loro procedimento di preparazione e loro impiego come sostanze medicinali.
MX15050A (es) Procedimiento para la preparacion de derivados de 1-arilsulfinil-2-pirrolidinona.
ES2081279T3 (es) Utilizacion de 15-desoxiespergualina como medicamento.
NO874780D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.
ES2061718T3 (es) Utilizacion de antigestagenos para la preparacion de medicamentos.
MX12003A (es) Procedimiento para la preparacion de composicionesherbicidas.
IT1215590B (it) Derivati della 1-benzene solfonil 2-oco 5-alchiltio pirrolidina, un loro procedimentodi preparazione e il loro impiegocome stostanze medicinali.
MX6790A (es) Procedimiento para la preparacion de nuevos derivados de aralquilimidazol, productos obtenidos y composicion farmaceutica que los incluye.
ES551864A0 (es) Procedimiento para la preparacion de glucosiloxicarbonilaminosulfonil derivados de nucleosidos.
ES554023A0 (es) Procedimiento para la produccion de derivados de acido-5-fenil carbamoil-tiobarbiturico.
MX12008A (es) Nuevos derivados de amino-acidos, procedimientos para su preparacion de los mismos y composicion farmaceutica que los contiene.
NO165235C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 2-substituerte-3,4-dihydroksyfenyletylamino-derivater.
MX13201A (es) Procedimiento para la preparacion de 4-aril-5carbamoil-1,4-dihidro-piridinas.
ES557824A0 (es) Procedimiento para la preparacion de derivados de pirido-benzotiacina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 305743

Country of ref document: ES